Paediatric brain tumours

British Medical Bulletin

Volumn 52, Issue 4, 1996, Pages 802-817

  Plowman, P N ^a,b   Brada, M ^c  

^a HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

BRAIN TUMOR; CHILDHOOD CANCER; DIAGNOSTIC IMAGING; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030459389     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011584     Document Type: Review

References (49)

1. von Deimling A, Krone W, Menon AG. Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 1995; 5: 153-62
2. van Meyel DJ, Ramsay DA, Chambers AF, Macdonald DR, Cairncross JG. Absence of hereditary mutations in exons 5 though 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma. Ann Neurol 1994; 35: 120-2
3. Twist EC, Ruttledge MH, Rousseau M et al. The neurofibromatosis type 2 gene is inactivated in Schwannomas. Hum Mol Genet 1993; 3: 147-51
4. Sanson M, Marineau C, Desmaze C et al. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet 1993; 2: 1215-20
5. Ruttledge MH, Xie YG, Han FY et al. Deletions on chromosome 22 in sporadic meningioma. Genes Chromosom Cancer 1994; 10: 122-30
6. Wellenreuther R, Kraus JA, Lenartz D et al. Analysis of neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995; 146: 827-32
7. Peyrard M, Fransson I, Xie YG et al. Characterisation of a new member of the human beta-adaptin gene family from chromosome 22q12, candidate meningioma gene. Hum Mol Genet 1994; 3: 1393-9
8. Jay B, Pienkowska M, Becker L, Zielenska M. Primitive neuroectodermal tumours of the cerebrum and cerebellum absence of t(11;22) translocation by PT-PCR analysis. Mod Pathol 1995; 8: 488-91
9. Evans DG, Farndon PA, Bumell LD, Gattamaneni HR, Birch JM. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991; 64: 959-61
10. Schofield D, West DC, Anthony DC, Marshal R, Sklar J. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol 1995; 146: 472-80
11. Fujii Y, Hongo T, Hayashi Y. Chromosome analysis of brain tumours in childhood. Genes Chromosom Cancer 1994; 11: 205-15
12. Vagner Capodane AM, Zattara Cannoni H, Gambarelli D et al. Detection of i(17q) chromosome by fluorescent in situ hybridisation (FISH) with interphase nuclei in medulloblastoma. Cancer Genet Cytogenet 1994; 78: 1-6
13. Eibl RH, Kleihues P, Jay PS, Wiestler OD. A model for primitive neuroectodermal tumours in transgenic neural transplants harboring the SV40 large T antigen. Am J Pathol 1994; 144: 556-64
14. Fung KM, Chikaraishi DM, Suri C et al. Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumours in four different lines of transgenic mice. Lab Invest 1994; 70: 114-24
15. Hamilton SR, Lui B, Parsons RE et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332: 839-47
16. Gilbertson RJ, Pearson AD, Perry RH, Jaros E, Kelly PJ. Prognostic significance of the c-erB-2 oncogene product in childhood medulloblastoma. Br J Cancer 1995; 71: 473-7
17. 18F) fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323-9
18. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK. PET of malignant cerebral tumours are interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 1988; 69: 830-8
19. Packer RJ, Lange B, Ater J et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 1993; 11: 850-6
20. Evans AE, Jenkins DT, Sposto R et al. The treatment of medulloblastoma: results of a prospective randomised trial of radiation therapy with and without CCNU, vincristine and prednisolone. J Neurosurg 1990; 72: 572-82
21. Tait D, Thornton-Jones H, Bloom H, Lemerle J, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990; 26 464-9
22. Packer RJ, Sutton LN, Goldwin JW et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991; 74: 433-40
23. Bailey CC, Gnekow A, Wellek S et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995; 25: 166-78
24. Dearnaley DP, A'Hern RP, Whittaker S, Blook HJG. Pineal and CNS germ cell tumours: Royal Marsden Hospital experience 1962-1987. Int J Radiat Oncol Biol Phys 1990; 18: 773-81
25. Shibamoto Y, Abe M, Yamashita J et al. Treatment results of intracranial germinoma as a function of the irradiated volume. Int J Radiat Oncol Biol Phys 1988; 15: 285-90
26. Duffner PK, Horowitz ME, Krischer JP et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumours. N Engl J Med 1993; 328: 1727-31
27. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumours. Science 1992; 256: 1550-2
28. Bloom HJG. Treatment of brain gliomas in children. In: Blechen NM ed Tumours of the Brain. Berlin: Springer, 1986; 121-40
29. Geyer JR, Finlay JL, Boyett JM et al. Cancer 1995; 75: 1045-50
30. Castello MA, Schiavetti A, Padula A et al. Does chemotherapy have a role in low grade astrocytoma management? A report of 13 cases. Med Pediatr Oncol 1995; 25: 102-8
31. Horwich A, Bloom HJG. Optic gliomas: radiation therapy and prognosis. Int J Radiat Oncol Biol Phys 1985; 11: 1067-79
32. Kedar A, Maria B, Graham-Pole J et al. High dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high risk brain tumours.
33. Cohen ME, Duffner PJ, Heffner R. Prognostic factor in brainstem gliomas. Neurology 1986; 36: 602-5
34. Packer RJ, Boyett JM, Zimmerman RA et al. Outcome of children with brainstem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. Cancer 1994; 74: 1827-34
35. Thorne RN, Pearson ADJ, Nicoll JAR et al. Decline in incidence of medulloblastoma. Cancer 1994; 74: 3240-4
36. Bailey CC Gnekow A, Wellek S et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medullohlasroma: SIOP II. Med Paediatr Oncol 1995; 25: 459-63
37. Allen JC, Walker R, Luks E. Carboplatin and recurrence childhood brain tumours. J Clin Oncol 1987; 5: 459-63
38. Loeffler JS, Kretsmar CS, Sallan SE. Preirradiation chemotherapy for infants and poor prognosis children with medulloblastoma. Int J Radiat Oncol Biol Phys 1988; 15: 177-81
39. Douek E, Plowman PN, Kingston JE. Platinum based chemotherapy for recurrent nongliomatous brain rumours in young patients. J Neurol Neurosurg Psychiatry 1991; 54: 722-5
40. Gentet JC, Doz F, Bouffet E et al. Carboplatin and VP16 in medulloblastoma: a phase II study of the French Society of Paediatric Oncology (SIOP). Med Pediatr Oncol 1994; 23: 422-7
41. Brada M, Rajan B. Spinal seeding in cranial germinoma. Br J Cancer 1990; 61: 339-40
42. Shibamoto Y, Oda Y, Yamashita J, Takahashi M, Kikuchi H, Abe M. The role of cerebrospinal fluid cytology in radiotherapy planning for intracranial germinoma. Int J Radiat Oncol Biol Phys 1994; 29: 1089-94
43. Shibamoto Y, Takahashi M, Abe M. Reduction of the radiation dose for intracranial germinoma: a prospective study. Br J Cancer 1994; 70: 984-9
44. Calaminus G, Bamberg M, Baranzelli MC et al. Intracranial germ cell tumours: a comprehensive update of the European data. Neuropaediatrics 1994; 25: 26-32
45. Brada M, Thomas DGT. Craniopharyngioma revisited. Int J Radiat Oncol Biol Phys 1993; 27: 471-5
46. Yasargil M, Curic M, Kis M, Siegenthaler G, Teddy P, Roth P. Total removal of craniopharyngiomas. Approaches and long-term results of 144 patients. J Neurosurg 1990; 73 3-11
47. Rajan B, Ashley S, Gorman C et al. Craniopharyngioma-Long term results following limited surgery and radiotherapy. Radiother Oncol 1993; 26: 1-10
48. Hetelekidis S, Barnes PD, Tao ML et al. 20-Year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 1993; 27: 189-95
49. Cohen ME, Duffner PK. Brain Tumours in Children: Principles of Diagnosis and Treatment. International Review of Child Neurology Series, 2nd Edn. New York: Raven, 1994